Search - tctmd.com

Displaying 121 - 133 of 133

Sort: Relevancy | Date

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Presenter: Mitchell W. Krucoff, Giulio G. Stefanini, Stephane Cook

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

Advertisement

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

EVERBIO II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting and Biolimus-Eluting Metallic Stents in Patients with Coronary Artery Disease

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

COMPARE II: BES, EES Show Similar Outcomes at Three Years

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content